KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Net Income (2016 - 2025)

Historic Net Income for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $670.0 million.

  • Boston Scientific's Net Income rose 1921.71% to $670.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.9 billion, marking a year-over-year increase of 5671.72%. This contributed to the annual value of $2.9 billion for FY2025, which is 5666.31% up from last year.
  • Boston Scientific's Net Income amounted to $670.0 million in Q4 2025, which was up 1921.71% from $756.0 million recorded in Q3 2025.
  • Boston Scientific's 5-year Net Income high stood at $795.0 million for Q2 2025, and its period low was $93.0 million during Q4 2021.
  • Over the past 5 years, Boston Scientific's median Net Income value was $380.0 million (recorded in 2021), while the average stood at $403.5 million.
  • In the last 5 years, Boston Scientific's Net Income skyrocketed by 331000.0% in 2021 and then plummeted by 6744.87% in 2022.
  • Quarter analysis of 5 years shows Boston Scientific's Net Income stood at $93.0 million in 2021, then skyrocketed by 51.61% to $141.0 million in 2022, then surged by 257.45% to $504.0 million in 2023, then grew by 11.51% to $562.0 million in 2024, then increased by 19.22% to $670.0 million in 2025.
  • Its last three reported values are $670.0 million in Q4 2025, $756.0 million for Q3 2025, and $795.0 million during Q2 2025.